Perspective Therapeutics Outperforms Competitors in Key Metrics

Perspective Therapeutics (CATX) shows stronger financial performance and analyst ratings compared to peers in the medical devices industry.

Published on Feb. 12, 2026

Got story updates? Submit your updates here. ›

Perspective Therapeutics (NASDAQ:CATX), a company in the 'Surgical, Medical, And Dental Instruments And Supplies' industry, has been compared to 28 of its public competitors. The analysis found that while Perspective Therapeutics' competitors have higher overall revenue, the company outperforms them in earnings per share, valuation, profitability metrics, and analyst recommendations.

Why it matters

This comparison highlights Perspective Therapeutics' competitive advantages within its industry, suggesting the company may be better positioned for growth and investor returns compared to its peers despite their larger size.

The details

The analysis found that Perspective Therapeutics has lower revenue but higher earnings per share than its competitors. It is also trading at a lower price-to-earnings ratio, indicating it is more affordable than other companies in the industry. Additionally, Perspective Therapeutics has stronger profit margins, return on equity, and return on assets compared to its peers. The company also has a higher consensus price target and more favorable analyst ratings than the industry group.

  • The analysis was published on February 13, 2026.

The players

Perspective Therapeutics

A public company in the 'Surgical, Medical, And Dental Instruments And Supplies' industry.

Isoray, Inc.

A company that develops, manufactures, and sells isotope-based medical products and devices for cancer treatment, based in Richland, Washington.

Got photos? Submit your photos here. ›

The takeaway

Perspective Therapeutics' strong financial performance and favorable analyst ratings suggest the company may be well-positioned to outperform its larger competitors in the medical devices industry, potentially making it an attractive investment option for investors seeking exposure to this sector.